Concentrix (CNXC.US) Price Target 2026/2027: 20% Upside – Rating and Stock Analysis

29.60
Share this analysis:

Concentrix Price Target 2026: Analysts See 22% Upside

The average price target for Concentrix is $36.25. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 22.47% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is Concentrix overvalued or undervalued?

Concentrix is currently undervalued with a gap of 22.5% relative to the price target.


The current price is $29.60, which places Concentrix in the undervalued category. The stock is considered undervalued when the price is below $32.63, and overvalued when the price exceeds $39.88.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Concentrix, the fair value range lies between $32.63 and $39.88.


See the full price target analysis for Concentrix →

Analyst Ratings for Concentrix stock in 2026: Buy

6 analysts cover Concentrix. The majority is positive, with 66.6% recommending Buy, while 33.3% recommend Hold. The average price target is $36.25, which gives an upside of 22.5% from the current price.

Consensus: Buy (4.00/5)
Strong Buy
2 (33.3%)
Buy
2 (33.3%)
Hold
2 (33.3%)
Strong Sell Sell Hold Buy Strong Buy
4.00 out of 5 based on 6 analysts

About Concentrix – Information Technology Services

Concentrix Corporation designs, builds, and runs integrated customer experience (CX) solutions worldwide. It provides CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services to clients in various industry verticals comprising technology and consumer electronics; retail, travel, and e-commerce; communications and media; banking, financial services, and insurance; and healthcare. The company also offers customer lifecycle management; CX and user experience strategy and design; data analytics, enterprise intelligence, artificial intelligence readiness, and actionable insights; digital operations, such as B2B sales, performance marketing, customer loyalty, trust and safety, collections, and financial compliance; and GenAI and agentic AI technologies. In addition, it provides digital transformation services that designs and engineer CX solutions to enable efficient customer self-service and build customer loyalty; customer engagement solutions and services that address the entirety of the customer lifecycle; and AI technology that can intelligently act on customer intent to improve customer experience with non-human engagement. Further, the company offers self-service GenAI and agentic AI assistants for applications in data analysis, language translations, and internal chatbots; voice of the customer and analytics solutions to gather and analyze customer feedback; analytics and consulting solutions that synthesize data and provide professional insight to improve clients' customer experience strategies; specialized support to specific industry verticals; and back office services that support clients in non-customer facing areas. It serves technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, healthcare, and other industries. The company was founded in 2004 and is based in Newark, California. Read more about the company

Key Figures for Concentrix

$ 1.7B Market cap
$ 10.0B Revenue
Information Technology Services Industry
- P/E
0.17 P/S
0.64 P/B
United States Listed on exchange

What kind of stock is Concentrix?

Dividend stock Growth stock

Concentrix is classified as a dividend stock and growth stock. This means the stock combines several attractive traits, including a dividend of 5.2%.

Score Overview for Concentrix

💰 Value Score 60/100 (High)
⭐ Quality Score 40/100 (Neutral)
🚀 Momentum Score 20/100 (Low)
📊 Total Score 40/100

⚠️ 4 red flags identified 1 critical

Our analysis has identified 4 potential risk factors in Concentrix that investors should be aware of.

⚠️ High debt: The debt-to-equity ratio is 197% – the company carries considerably more debt than equity, which raises the financial risk.
⚠️ Negative profit margin: The profit margin is -13.2% – the company is losing money on its operations.
🚨 Negative return on equity: ROE is -37.7% – the company is generating a negative return for shareholders.
⚠️ High short interest: 18.1% of the shares are sold short – many professional investors are betting on price declines.

📈 Valuation

The P/S ratio is 0.2 (low — potentially undervalued relative to revenue). The P/B ratio is 0.6, below book value, which can point to a value opportunity. The PEG ratio is 0.36 — below 1.0 suggests the stock is cheap relative to its growth rate.

💵 Profitability & Growth

Concentrix and an operating margin of 7.9%. Return on assets (ROA) is 3.4%. The latest quarterly earnings grew 36.1% year over year — strong growth.

🏦 Financial Health

The Piotroski score is 7 out of 9 — good financial health. The debt-to-equity ratio (D/E) is 196.8% — moderate debt.

🚀 Momentum & Short Interest

Short interest is 18.05% — very high, the market is skeptical.

Concentrix Dividend 2026: 5.2% Dividend Yield

Dividend Key Figures for Concentrix in 2026

Dividend yield
5.23%
Payout ratio
13.5%
Low

When does Concentrix pay a dividend in 2026?

Next dividend payment
August 4, 2026

How much does Concentrix pay in dividends?

Concentrix does not currently pay a dividend. This may be because the company reinvests its profits in growth, or because there is not enough profit for dividend payments. You can find more information about the dividend policy on the company's website.

Historical Dividend Payments for Concentrix

No historical dividend payments are registered for this stock.

Ex-datePayment dateAmountCurrencyPeriod
No historical dividend payments available.

Insider Trading in Concentrix 2026: The Signal Is clearly positive

In 2026, insiders at Concentrix have made 20 transactions – split into 4 purchases and 16 sales. On a net basis, insiders took 134,006,142 $ out of the stock. Active insiders include Caldwell Christopher A, Valentine Andre S, Groupe Bruxelles Lambert and others. In the short term (last 3 months), the insider signal is clearly positive.

Short-Term Signal (3 months): Clearly positive

Insiders have exclusively bought shares over the last 3 months. This is a strong signal of confidence in the company in the short term.

Over the last 3 months: 1 purchases and 0 sales. A net 21,250 $ into the stock.

Long-Term Signal (all transactions): Mostly negative

Insiders have sold considerably more than they have bought. At large companies this can be due to planned sales (10b5-1 plans) and is not necessarily a negative signal.

Across the last 20 transactions: 4 purchases and 16 sales. A net 134,006,142 $ out of the stock.

Latest purchase: Caldwell Christopher A bought 1,000 shares at 21 $ each on 2026-07-08. The stock has since risen 37.7%.

Latest sale: Groupe Bruxelles Lambert sold 6,000,000 shares at 22 $ each on 2026-04-29.

Who is buying: Caldwell Christopher A, Valentine Andre S.

Who is selling: Groupe Bruxelles Lambert, Valentine Andre S, Twomey Cormac J, Gibson Craig, Fogarty Jane and others.

Latest Insider Trades in Concentrix (2026)

The table shows the last 20 reported insider transactions in Concentrix. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-07-08 Caldwell Christopher A Buy 1,000 21 21,250
2026-04-29 Groupe Bruxelles Lambert Sell 6,000,000 22 133,500,000
2026-04-09 Valentine Andre S Buy 2,500 28 69,875
2026-03-26 Caldwell Christopher A Buy 1,000 27 26,970
2026-02-01 Valentine Andre S Sell 864 37 32,270
2026-02-01 Twomey Cormac J Sell 1,439 37 53,747
2026-02-01 Gibson Craig Sell 799 37 29,843
2026-02-01 Fogarty Jane Sell 563 37 21,028
2026-02-01 Caldwell Christopher A Sell 5,693 37 212,634
2026-01-29 Caldwell Christopher A Buy 1,000 37 37,070

Who is buying and selling Concentrix shares in 2026?

The following insiders have bought shares in Concentrix: Caldwell Christopher A, Valentine Andre S. In total, 155,165 $ was bought across 4 transactions. The following insiders have sold shares: Groupe Bruxelles Lambert, Valentine Andre S, Twomey Cormac J, Gibson Craig, Fogarty Jane and others. In total, 134,161,307 $ was sold across 16 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Concentrix Short Selling 2026: 18.1% Sold Short

Very high short interest: 18.1% of the free float
Short % of free float
18.1%
Assessment
Very high short interest
Short squeeze risk
High
Data source
SEC
Updated daily
The stock has a very high share of short selling. Between 10-20% of the freely traded shares are sold short, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains.

What does this mean for you as an investor?
A short interest of 18.1% means that 18.1% of the freely traded shares in Concentrix have been borrowed and sold by investors betting on falling prices. On positive surprises (e.g. a strong earnings report), short sellers can be forced to buy back shares quickly to close their positions, which can cause a short squeeze with sharp price gains in a short time.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
18.1%

When Does Concentrix Report Earnings?

The next earnings date for Concentrix is not yet available. Check the company's investor calendar for more information.



Technical Analysis of Concentrix 2026 – Signal: Hold

Overall Technical Signal: Hold

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated September 15, 2026.

Trend Analysis of Concentrix Corporation

Concentrix Corporation is in a short-term uptrend. The price of $29.27 is 4.3% above the 20-day average ($28.06). Medium term, the picture is positive: the price is 13.8% above the 50-day average ($25.72). Long term, the stock is 1.6% below the 200-day average ($29.75), which signals a long-term downtrend.

Death Cross: The 50-day average (25.72) is below the 200-day average (29.75), which is a classic bearish signal for Concentrix Corporation.

Is Concentrix Corporation overbought or oversold?

Concentrix Corporation has an RSI of 55.9. The stock shows positive momentum in the upper part of the neutral zone.

MACD Analysis for Concentrix Corporation

Daily MACD: MACD is positive (0.975), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is below the signal line (1.218) by 0.243, which suggests the positive momentum is fading – the trend could be turning.

Weekly MACD: MACD5 is negative (-1.150), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-2.423) by 1.273, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: The daily and weekly MACD give conflicting signals. The short-term trend is bullish, but the long-term trend is still bearish. Weekly momentum is rising, though, which could signal an upcoming trend reversal.

Risk Profile for Concentrix Corporation

Concentrix Corporation has an annual standard deviation of 67.7%, which classifies the stock as Speculative. Sizeable price swings are normal, and the stock requires a higher risk tolerance.

Overall Technical Conclusion for Concentrix Corporation

Trend: Neutral/mixed.

MACD trend (zero line): Daily bullish (0.975). Weekly bearish (-1.150).

MACD momentum (signal): Daily falling. Weekly rising.

RSI: 55.9 – neutral.

Technical signal: Hold

The signals are mixed – trend and MACD point in different directions. Wait until MACD crosses the zero line in the direction of the trend before acting.

Frequently Asked Questions About Concentrix stock in 2026

Should you buy Concentrix stock now?
The technical signal for Concentrix is currently NEUTRAL. Concentrix trades at $29.60 as of 9/15/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is positive (bullish trend) at 0.975 with falling momentum (signal: 1.218); RSI is at 55.9 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $36.25 points to 22.5% upside. This is a technical observation based on current data, not investment advice.
What is the price target for Concentrix stock?
The average analyst price target for Concentrix is $36.25. The current price is $29.60, which gives an upside of 22.5%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $32.63 and $39.88.
Is Concentrix a dividend stock?
Yes, Concentrix is a dividend stock with a dividend yield of 5.23%. The payout ratio is 13.5%, which is considered sustainable. The next dividend payment is scheduled for 8/4/2026.
When does Concentrix pay a dividend in 2026?
Concentrix pays its next dividend on 8/4/2026. The dividend yield is 5.23%. The payout ratio of 13.5% points to a sustainable dividend with room to grow.
What is the risk of Concentrix stock?
Concentrix is rated as a stock in the risk category Speculative. the annual standard deviation is 67.7%, which classifies the stock as Speculative.
Is Concentrix overvalued?
No, Concentrix is considered undervalued based on the analyst price target (22.5% upside). Concentrix has the following valuation ratios: a P/S ratio of 0.2, a P/B ratio of 0.6. The analyst price target suggests that the stock is undervalued by 22.5%.
Is Concentrix overbought?
No, Concentrix is not overbought. RSI is at 55.9 (neutral zone). The technical indicators show: RSI is at 55.9 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 5.5% above the 20-day average (short-term uptrend). In addition, MACD is positive, but momentum is falling.
When is the next Concentrix earnings report?
The date of the next earnings report for Concentrix has not been published yet. Check the company's investor calendar for updates.
Is Concentrix shorted?
Yes, Concentrix is shorted with 18.1% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying Concentrix stock?
Yes, insiders are net buyers of Concentrix – they are buying more shares than they are selling. Over the last 3 months, insiders have made 1 purchases and 0 sales. On a net basis, 21,250 $ worth of shares were bought. Across the last 20 reported transactions, the split is 4 purchases and 16 sales, with a net 134,006,142 $ sold. Active buyers include Caldwell Christopher A, Valentine Andre S. Insider buying is generally seen as a positive signal, because management is putting its own money into the company.
Is Concentrix a good stock?
Based on our total score, Concentrix is rated as a mediocre stock with a total score of 40 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 60/100, Quality: 40/100, Momentum: 20/100. In addition: analysts see 22.5% upside to the price target; a dividend of 5.23%; technical signal: Hold. Whether Concentrix is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Concentrix stock?
The outlook for Concentrix based on current data: the average analyst price target is $36.25 (+22.5%). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Concentrix stock rising?
Concentrix is rising right now. The technical indicators show: the price is 5.5% above the 20-day average; short interest is 18.1% (high – many are betting on a decline); insiders have mostly been buying the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Concentrix go?
The average analyst price target for Concentrix is $36.25, which corresponds to a potential gain of 22.5% from the current price of $29.60. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Concentrix fall?
We lack enough history to give a specific floor for Concentrix. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Concentrix do?
Concentrix Corporation designs, builds, and runs integrated customer experience (CX) solutions worldwide. It provides CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services to cl... The company belongs to the Technology sector, more specifically the Information Technology Services industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Concentrix as an investment.
Did Concentrix raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Concentrix. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Concentrix making money or losing money?
No, Concentrix is currently not making money — the company is losing money with a negative profit margin of -13.2%, a noticeable loss. That means the business loses money on every dollar of revenue. The operating margin, however, is positive at 7.9% — the core business makes money; the loss comes from financing costs, taxes or one-off items. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Concentrix go bankrupt?
We have no current data to calculate the bankruptcy risk for Concentrix. Check the latest report and the debt level in the key figures section above.
Does Concentrix have a lot of debt?
Yes, Concentrix has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 197%. For the technology sector, anything above 120% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Tech companies are usually asset-light and need little borrowed capital — anything below 60% counts as low in this sector. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Concentrix service its debt? Can service its debt, but it weighs on the company — the interest coverage ratio (how many times earnings can cover interest payments) is 2.0x, and net debt equals 3.4 years of earnings (EBITDA).

Other Stocks in Technology

Compare Concentrix with other stocks in the technology sector. Click a stock to see its technical analysis, insider trading and key figures.

See all 188 stocks in the Technology sector